West Pharmaceutical Services | WST - Marktkapitalisierung

Aktienkurs
306.16
Täglich Wechseln
-3.54 -1.14%
Monatlich
23.94%
Jährlich
42.70%
Q2 Prognose
299.61




Marktkapitalisierung Veränderung Datum
Align Technology USD 11.2B 2.13B 2025-12
Avanos Medical USD 521M 15M 2025-12
Baxter International USD 9.82B 1.87B 2025-12
Becton, Dickinson and Co. USD 55.29B 1.64B 2025-12
Cerus USD 286M 36M 2024-12
Charles River Laboratories USD 10.02B 2.71B 2025-12
Cooper Companies USD 15.95B 2.05B 2025-12
Dentsply International USD 2.28B 251M 2025-12
Haemonetics USD 3.76B 1.44B 2025-12
ICU Medical USD 3.52B 561M 2025-12
Insulet USD 20B 1.74B 2025-12
Integra LifeSciences USD 967M 150M 2025-12
IQVIA Holdings USD 29.18B 9.2B 2026-04
J&J USD 561.65B 17.5B 2026-04
Merit Medical Systems USD 5.23B 297M 2025-12
Neogen USD 2.22B 221M 2026-04
OraSure Technologies USD 174M 61M 2025-12
Quidel USD 1.99B 66M 2025-12
Repligen USD 9.22B 1.7B 2025-12
STAAR Surgical USD 1.17B 149M 2025-12
Utah Medical Products USD 225M 47M 2026-04
West Pharmaceutical Services USD 22.67B 4.61B 2026-04
WK Kellogg Co USD 13.74B 1.09B 2025-12